Cargando…
Health Outcomes at School Age among Children Who Are HIV-Exposed but Uninfected with Detected Mitochondrial DNA Depletion at One Year
Infant antiretroviral (ARV) prophylaxis given to children who are human immunodeficiency virus (HIV)-exposed but uninfected (CHEU) to prevent HIV transmission through breastfeeding previously proved its efficacy in the fight against the pediatric epidemic. However, few studies have investigated the...
Autores principales: | Monnin, Audrey, Nagot, Nicolas, Eymard-Duvernay, Sabrina, Meda, Nicolas, Tumwine, James K., Tylleskär, Thorkild, de Perre, Philippe Van, Molès, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696966/ https://www.ncbi.nlm.nih.gov/pubmed/33207772 http://dx.doi.org/10.3390/jcm9113680 |
Ejemplares similares
-
Longitudinal Follow-Up of Blood Telomere Length in HIV-Exposed Uninfected Children Having Received One Year of Lopinavir/Ritonavir or Lamivudine as Prophylaxis
por: Monnin, Audrey, et al.
Publicado: (2021) -
Mitochondrial DNA Instability Is Common in HIV-Exposed Uninfected Newborns
por: Monnin, Audrey, et al.
Publicado: (2021) -
Long-Term Persistence of Mitochondrial DNA Instability in HIV-Exposed Uninfected Children during and after Exposure to Antiretroviral Drugs and HIV
por: Desquiret-Dumas, Valérie, et al.
Publicado: (2022) -
Mitochondrial DNA Parameters in Blood of Infants Receiving Lopinavir/Ritonavir or Lamivudine Prophylaxis to Prevent Breastfeeding Transmission of HIV-1
por: Monnin, Audrey, et al.
Publicado: (2020) -
Growth, clinical and neurodevelopmental outcomes at school age are similar for children who received 1-year lamivudine or lopinavir/ritonavir HIV prophylaxis in early life
por: Nagot, Nicolas, et al.
Publicado: (2021)